T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding

被引:9
作者
Dewitz, Christin [1 ]
Moeller-Hackbarth, Katja [1 ]
Schweigert, Olga [1 ]
Reiss, Karina [2 ]
Chalaris, Athena [1 ]
Scheller, Juergen [3 ]
Rose-John, Stefan [1 ]
机构
[1] Univ Kiel, Inst Biochem, Fac Med, Kiel, Germany
[2] Univ Kiel, Dept Dermatol, Kiel, Germany
[3] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany
关键词
ADAM10; calmodulin; ferritin; shedding; T-cell immunoglobulin and mucin domain2; SOLUBLE INTERLEUKIN-6 RECEPTOR; IL-6; RECEPTOR; L-SELECTIN; FACTOR-ALPHA; H-FERRITIN; ADAM10; PROTEIN; DISINTEGRIN; CLEAVAGE; ADHESION;
D O I
10.1111/febs.12583
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-cell immunoglobulin and mucin domain (TIM)-2 is expressed on activated Bcells. Here, we provide evidence that murine TIM-2 is a target of ADAM10-mediated ectodomain shedding, resulting in the generation of a soluble form of TIM-2. We identified ADAM10 but not ADAM17 as the major sheddase of TIM-2, as shown by pharmacological ADAM10 inhibition and with ADAM10-deficient and ADAM17-deficient murine embryonic fibroblasts. Ionomycin-induced or 2(3)-O-(4-benzoylbenzoyl) ATP triethylammonium salt-induced shedding of TIM-2 was abrogated by deletion of 10 juxtamembrane amino acids from the stalk region but not by deletion of two further N-terminally located blocks of 10 amino acids, indicating a membrane-proximal cleavage site. TIM-2 lacking the intracellular domain was cleaved after ionomycin or 2 (3)-O-(4-benzoylbenzoyl) ATP triethylammonium salt treatment, indicating that this domain was not involved in the regulation of ectodomain shedding. Moreover, TIM-2 shedding was negatively controlled by calmodulin. Shed and soluble TIM-2 interacted with H-ferritin. In summary, we describe TIM-2 as a novel target for ADAM10-mediated ectodomain shedding, and reveal the involvement of ADAM proteases in cellular iron homeostasis.
引用
收藏
页码:157 / 174
页数:18
相关论文
共 50 条
[41]   MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia [J].
Viny, Aaron D. ;
Clemente, Michael J. ;
Jasek, Monika ;
Askar, Medhat ;
Ishwaran, Hemant ;
Nowacki, Amy ;
Zhang, Aiwen ;
Maciejewski, Jaroslaw P. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10) :1713-1721
[42]   Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice [J].
Horst, Andrea Kristina ;
Wegscheid, Claudia ;
Schaefers, Christoph ;
Schiller, Birgit ;
Neumann, Katrin ;
Lunemann, Sebastian ;
Langeneckert, Annika E. ;
Oldhafer, Karl J. ;
Weiler-Normann, Christina ;
Lang, Karl S. ;
Singer, Bernhard B. ;
Altfeld, Marcus ;
Diehl, Linda ;
Tiegs, Gisa .
HEPATOLOGY, 2018, 68 (01) :200-214
[43]   Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy [J].
Chaudhuri, Suhnrita ;
Bhattacharya, Debanjan ;
Singh, Manoj Kumar ;
Moitra, Saibal ;
Ronsard, Larance ;
Ghosh, Tushar Kanti ;
Chaudhuri, Swapna .
MOLECULAR IMMUNOLOGY, 2015, 67 (02) :256-264
[44]   PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation [J].
Yan, Pengrong ;
Fu, Jing ;
Qu, Zhaoxia ;
Li, Shirong ;
Tanaka, Takashi ;
Grusby, Michael J. ;
Xiao, Gutian .
BLOOD, 2009, 113 (18) :4370-4380
[45]   A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy [J].
Fox, Christopher P. ;
Haigh, Tracey A. ;
Taylor, Graham S. ;
Long, Heather M. ;
Lee, Steven P. ;
Shannon-Lowe, Claire ;
O'Connor, Simon ;
Bollard, Catherine M. ;
Iqbal, Javeed ;
Chan, Wing C. ;
Rickinson, Alan B. ;
Bell, Andrew I. ;
Rowe, Martin .
BLOOD, 2010, 116 (19) :3695-3704
[46]   A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia [J].
Nair-Gupta, Priyanka ;
Diem, Michael ;
Reeves, Dara ;
Wang, Weirong ;
Schulingkamp, Robert ;
Sproesser, Katrin ;
Mattson, Bethany ;
Heidrich, Bradley ;
Mendonca, Mark ;
Joseph, Jocelin ;
Sendecki, Jocelyn ;
Foulk, Brad ;
Chu, Gerald ;
Fink, Damien ;
Jiao, Qun ;
Wu, Sheng-Jiun ;
Packman, Kathryn ;
Elsayed, Yusri ;
Attar, Ricardo ;
Gaudet, Francois .
BLOOD ADVANCES, 2020, 4 (05) :906-919
[47]   Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation [J].
Martinez, Nicole M. ;
Agosto, Laura ;
Qiu, Jinsong ;
Mallory, Michael J. ;
Gazzara, Matthew R. ;
Barash, Yoseph ;
Fu, Xiang-dong ;
Lynch, Kristen W. .
GENES & DEVELOPMENT, 2015, 29 (19) :2054-2066
[48]   Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways [J].
Naji, Abderrahim ;
Durrbach, Antoine ;
Carosella, Edgardo D. ;
Rouas-Freiss, Nathalie .
HUMAN IMMUNOLOGY, 2007, 68 (04) :233-239
[49]   The Receptor Complex Associated with Human T-Cell Lymphotropic Virus Type 3 (HTLV-3) Env-Mediated Binding and Entry Is Distinct from, but Overlaps with, the Receptor Complexes of HTLV-1 and HTLV-2 [J].
Jones, Kathryn S. ;
Huang, Ying K. ;
Chevalier, Sebastien A. ;
Afonso, Philippe V. ;
Petrow-Sadowski, Cari ;
Bertolette, Daniel C. ;
Gessain, Antoine ;
Ruscetti, Francis W. ;
Mahieux, Renaud .
JOURNAL OF VIROLOGY, 2009, 83 (10) :5244-5255
[50]   Induction of NKG2D ligand expression on tumor cells by CD8+ T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor [J].
Hu, Jiemiao ;
Xia, Xueqing ;
Gorlick, Richard ;
Li, Shulin .
ONCOGENE, 2019, 38 (49) :7433-7446